Le Lézard
Classified in: Health
Subject: SVY

Researchers Say 30% of Patients Taking Opioids Experience Adverse Drug Interactions


CHICAGO, Dec. 10, 2019 /PRNewswire/ -- Patients who do not disclose use of other medications are at higher risk of adverse drug interactions and addiction, according to new research in The Journal of the American Osteopathic Association.

American Osteopathic Association logo

A new article outlines common drug-drug interactions that alter how the body metabolizes certain opioids, causing decreased efficacy that ultimately can lead to misuse and overdose. The authors estimate that around 30 percent of patients experience such interactions; however, very few are detected and reported.

"The concern we have is that patients may not get the proper amount of pain relief due to an undetected interaction with some other medication they're taking," says Kevin Bain, MPH, PharmD, co-founder and medical director at Biophilia Partners and lead author on this article. "That can lead to them taking higher doses of their prescribed opioid and more frequently, which over time can lead to a substance use disorder or even an overdose."

Bain adds that physicians should take a thorough medication history and consult a pharmacist before prescribing opioids if they have any concerns. However, he encourages patients to advocate for themselves by offering relevant information proactively.

He says commonly prescribed medications that can cause interactions with several opioids include those from antidepressant and antipsychotic classes, as well as some cardiovascular drugs used to treat arrhythmia and high blood pressure.

Preventing complications

The article notes several steps physicians can take to mitigate adverse interactions, when patients take opioids and other medications concurrently.

Patients often take all their medications at once, usually in the morning, to establish a routine and ensure none are forgotten. Bain points out that this method significantly increases the likelihood of a drug interaction.

He recommends staggering the interacting medications a couple hours apart, often taking the opioid first to ensure it metabolizes without interference, because pro-drug opioids like codeine and tramadol usually "suffer" from drug interactions.

When timing fails to avoid drug interactions, physicians can prescribe an alternate opioid less likely to interact with the patient's other medications. Conversely, physicians can consider changing the non-opioid prescription to one less likely to cause an interaction.

"The possible combinations that might result in a drug interaction are vast," says Bain. "The best approach is for physicians and patients to partner closely with a pharmacist who can advise on potential complications, especially at the start of an opioid prescription."

He adds that patients who find an opioid ineffectively manages their pain should consult their physician and never independently alter their dosage or frequency. Communication between patients and physicians is paramount to identifying and mitigating opioid-involved drug interactions, Bain concludes.

About The Journal of the American Osteopathic Association

The Journal of the American Osteopathic Association (JAOA) is the official scientific publication of the American Osteopathic Association. Edited by Robert Orenstein, DO, it is the premier scholarly peer-reviewed publication of the osteopathic medical profession. The JAOA's mission is to advance medicine through the publication of peer-reviewed osteopathic research.

SOURCE American Osteopathic Association


These press releases may also interest you

at 00:01
A new National Safety Council report reveals 39 states did not go far enough to protect residents from the century's biggest threat to safety. Despite COVID-19 claiming more lives than accidental drug overdoses, motor vehicle crashes and falls...

at 00:00
To coincide with World Heart Day on September 29th, the Magdi Yacoub Global Heart Foundation, a leading nonprofit charity that improves comprehensive, advanced cardiac care for children is thrilled to announce a partnership with the award-winning IT...

28 sep 2020
The food recall warning issued on September 27, 2020 has been updated to include additional product information. The food recall warning issued on September 27, 2020 has also been amended to correctly identify the affected products. The corrections...

28 sep 2020
Today, the U.S. Food and Drug Administration issued the final guidance, "Breast Implants - Certain Labeling Recommendations to Improve Patient Communication," as part of the agency's effort to help improve the information available to patients and...

28 sep 2020
The Global Health Innovative Technology (GHIT) Fund announced today a total of 1.37 billion yen (US$13 million*) to invest in seven partnerships to develop new lifesaving drugs and diagnostics for malaria, Buruli ulcer, Chagas disease, leishmaniasis,...

28 sep 2020
Government of Canada officials will hold a technical briefing to provide an overview on the authorization of coronavirus testing applications and devices (COVID-19). DateSeptember 29, 2020 Time10:30 AM (EDT) LocationMedia Technical Briefing will be...



News published on 10 december 2019 at 16:24 and distributed by: